About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Nashville | 10,878 Studies Near You

Clinical TrialsNashville

Clinical Trials in Nashville

Discover 10,878 clinical trials near Nashville, Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 61-80 of 10,878 trials

TerminatedA Study to Evaluate Long Term Safety and Efficacy of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary FibrosisThis study will evaulate the long-term safety, efficacy and pharmacokinetics (PK) of recombinant human pentraxin-2 (rhPTX-2; PRM-151) zinpentraxin alfa, administered by…NCT04594707·Birmingham, Alabama and 247 others

Find Trials by Condition in Nashville

Breast Cancerin Nashville Lung Cancerin Nashville Prostate Cancerin Nashville Colorectal Cancerin Nashville Melanomain Nashville Leukemiain Nashville Lymphomain Nashville Pancreatic Cancerin Nashville Ovarian Cancerin Nashville Brain Cancerin Nashville

Data from ClinicalTrials.govTerms

CompletedClot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase IIIThe overall objective of this Phase III clinical trial is to obtain information from a population of 500 ICH subjects with intraventricular hemorrhage (IVH), representative of…NCT00784134·Birmingham, Alabama and 80 others

Active not recruitingEfficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)Researchers are looking for new ways to treat high-risk non muscle invasive bladder cancer (HR NMIBC).NCT03711032·Anchorage, Alaska and 208 others

CompletedErlotinib and Bevacizumab in Treating Patients With Stage IV MelanomaRATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00466687·Nashville, Tennessee and 3 others

RecruitingReducing Overuse of Antibiotics With Decision SupportEliminating inappropriate antibiotic use in pediatric lower respiratory tract infections (LRTI) is the central focus of this research.NCT06788093·Oakland, California and 2 others

CompletedPancreatic Cancer Serum and DNA RepositoryTo prospectively collect serum and DNA samples from subjects with pancreatic cancer, pancreatitis, liver disease, and from healthy and at-risk volunteers in order to identify…NCT00296114·Scottsdale, Arizona and 9 others

CompletedAcoustical Properties of Speech as Indicators of Suicidal RiskThis project is focused on acoustical, sound, analysis of speech in order to identify vocal characteristics of speech that are associated with suicidality.NCT00178906·Nashville, Tennessee

RecruitingAn Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid TumorsThe primary objectives of this trial are to: * Characterize the safety and tolerability of TEV-56278 * Determine the Recommended Phase 2 Dose (RP2D) * Evaluate antitumor activity…NCT06480552·Los Angeles, California and 11 others

RecruitingOpen-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)This is a Phase 3 global, multicenter, 52-week, open-label extension (OLE) rollover study for subjects completing study CN012-0026, CN012-0027 or CN012-0056.NCT05980949·Homewood, Alabama and 431 others

TerminatedEfficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial SeizuresThis study will determine the safety and efficacy of pregabalin (Lyrica) when administered by itself (without any other anti-epileptic medication) to epilepsy subjects for the…NCT00524030·Northport, Alabama and 72 others

TerminatedA Study of the Effects of AB-205 in Patients With Lymphoma Undergoing Autologous Hematopoietic Cell TransplantationHigh-dose chemotherapy followed by blood stem cell transplantation is administered to lymphoma patients with an intention to cure.NCT05181540·Gilbert, Arizona and 27 others

CompletedPivotal IDE Study of the BRYAN(R) Cervical Disc Prosthesis in the Treatment of DDD Versus ACDFThe purpose of this study is to establish the safety and effectiveness of the BRYAN(R) Cervical Disc Prosthesis in treating single-level degenerative disc disease of the cervical…NCT00437190·Phoenix, Arizona and 37 others

CompletedPemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck CancerRATIONALE: Pemetrexed may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00503997·Owensboro, Kentucky and 6 others

TerminatedPhase 1/2 Study of Mocetinostat and Durvalumab in Patients With Advanced Solid Tumors and NSCLCMocetinostat (MGCD0103) is an orally administered HDAC inhibitor.NCT02805660·Mobile, Alabama and 14 others

CompletedCombination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk MedulloblastomaThis randomized phase III trial is studying two different combination chemotherapy regimens to compare how well they work in treating young patients with newly diagnosed…NCT00336024·Birmingham, Alabama and 144 others

TerminatedA Study of the In-Space Device for Treatment of Moderate Spinal StenosisThe purpose of this study is to evaluate the safety and effectiveness of the In-Space compared to the X STOP Interspinous Process Distraction (IPD) device ("X STOP") for the…NCT00697827·Santa Monica, California and 9 others

CompletedObese Patients With or Without Comorbidities (RIO-North America)To assess the effects of weight loss and weight maintenance over a period of two years when prescribed with a hypocaloric diet in obese patients with or without comorbiditiesNCT00029861·Birmingham, Alabama and 50 others

CompletedEffect of Food on Blood Levels of ASTX727This study is designed to examine blood levels of ASTX727, a fixed-dose combination tablet containing the combination of cedazuridine (100 mg) and decitabine (35 mg), when given…NCT03813186·Buffalo, New York and 3 others

WithdrawnStudy of BXCL501 In Agitation Associated With Delirium in ICU PatientsThis study is designed to determine and evaluate the optimal BXCL501 starting dose (StartD) that will safely and effectively reduce agitation associated with delirium in ICU…NCT05313386·Nashville, Tennessee

CompletedEffect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol LevelsThe purpose of this study is to compare changes in cholesterol levels in patients with elevated blood cholesterol with administration of lapaquistat acetate, once daily (QD), and…NCT00813527·Huntsville, Alabama and 35 others

PreviousPage 4 of 544Next

Diabetes

in Nashville

Heart Diseasein Nashville